相似文献/References:
[1]田汝银 赖铭莹.Bevacizumab在新生血管性青光眼治疗中的应用[J].眼科新进展,2010,30(4):000.
[2]黄志坚 宋艳萍 金中秋 丁琴 陈中山.光动力疗法联合玻璃体内注射Bevacizumab治疗病理性近视合并脉络膜新生血管[J].眼科新进展,2013,33(4):000.
[3]薛艳,侯光辉,纪虹,等.巩膜环扎术治疗孔源性视网膜脱离术后的眼表改变[J].眼科新进展,2010,30(5):000.
[4]张敏,储三军,曾繁星,等. Bevacizumab对视网膜色素上皮细胞纤维化相关因子表达的影响[J].眼科新进展,2014,34(4):318.[doi:10.13389/j.cnki.rao.2014.0086]
[5]王俊,孟晓光,李秀云,等.Bevacizumab玻璃体内注射联合视网膜光凝及冷凝治疗新生血管性青光眼[J].眼科新进展,2014,34(6):557.[doi:10.13389/j.cnki.rao.2014.0152]
[6]李静,谢安明,张坚,等. Bevacizumab对人Tenon囊成纤维细胞转分化的抑制作用[J].眼科新进展,2015,35(7):615.[doi:10.13389/j.cnki.rao.2015.0167]
LI Jing,XIE An-Ming,ZHANG Jian,et al. Inhibitive effects of Bevacizumab on transdifferentiation of human Tenon capsule fibroblasts[J].Recent Advances in Ophthalmology,2015,35(5):615.[doi:10.13389/j.cnki.rao.2015.0167]
[7]陈小红,王云鹏,陈梅珠. VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J].眼科新进展,2015,35(7):692.[doi:10.13389/j.cnki.rao.2015.0190]
CHEN Xiao-Hong,WANG Yun-Peng,CHEN Mei-Zhu. Role of VEGF in pathogenesis of diabetic retinopathy and anti-VEGF therapy[J].Recent Advances in Ophthalmology,2015,35(5):692.[doi:10.13389/j.cnki.rao.2015.0190]